Huijts, Charlotte M <br/><br/>
Differential effects of inhibitors of the PI3K/mTOR pathway on the expansion and functionality of regulatory T cells.  [electronic resource] 

 -  Clinical immunology (Orlando, Fla.)  07 2016 
 - 47-54 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1521-7035 
<br/><br/><label>Standard No.: </label>10.1016/j.clim.2016.05.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aminopyridines--pharmacology<br/>Antineoplastic Agents--pharmacology<br/>Blotting, Western<br/>Cell Proliferation--drug effects<br/>Cells, Cultured<br/>Cytokines--immunology<br/>Everolimus--pharmacology<br/>Flow Cytometry<br/>Humans<br/>Imidazoles--pharmacology<br/>Morpholines--pharmacology<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Quinolines--pharmacology<br/>Signal Transduction--drug effects<br/>Sirolimus--pharmacology<br/>T-Lymphocytes, Regulatory--cytology<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors